StockData

Orchestra BioMed Holdings, Inc. (OBIO) bonds

OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$6.97−0.15 (-2.11%)

Close on Nov 17, 2026Market cap $418.93MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Orchestra BioMed reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Orchestra BioMed's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issuedCarrying value
2024 Loan and Security AgreementFloating + 2.00%$50.00M$15.00M
Tranche four loan and security agreement–$20.00M–
Tranche one loan and security agreement–$15.00M–
Tranche two and three loan and security agreement–$15.00M–
Tranche two loan and security agreement–$35.00M–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?